Details for New Drug Application (NDA): 220374
NDA 220374 describes FIDAXOMICIN, which is a drug marketed by Actavis Labs Fl, Apotex, Hikma, Sandoz, and Torrent, and is included in five NDAs. It is available from five suppliers. Additional details are available on the FIDAXOMICIN profile page.
The generic ingredient in FIDAXOMICIN is fidaxomicin. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the fidaxomicin profile page.
The generic ingredient in FIDAXOMICIN is fidaxomicin. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the fidaxomicin profile page.
Summary for 220374
| Tradename: | FIDAXOMICIN |
| Applicant: | Torrent |
| Ingredient: | fidaxomicin |
| Patents: | 0 |
Suppliers and Packaging for NDA: 220374
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| FIDAXOMICIN | fidaxomicin | TABLET;ORAL | 220374 | ANDA | Torrent Pharmaceuticals Limited | 13668-745 | 13668-745-21 | 20 TABLET, FILM COATED in 1 BOTTLE (13668-745-21) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
| Approval Date: | Jan 27, 2026 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
